Renalytix Ai Stock Performance
RNLX Stock | USD 0.64 0.06 8.57% |
Renalytix holds a performance score of 9 on a scale of zero to a hundred. The company holds a Beta of -0.92, which implies possible diversification benefits within a given portfolio. As the market becomes more bullish, returns on owning Renalytix are expected to decrease slowly. On the other hand, during market turmoil, Renalytix is expected to outperform it slightly. Use Renalytix potential upside, as well as the relationship between the accumulation distribution and period momentum indicator , to analyze future returns on Renalytix.
Risk-Adjusted Performance
9 of 100
Weak | Strong |
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Renalytix AI are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. In spite of fairly uncertain essential indicators, Renalytix showed solid returns over the last few months and may actually be approaching a breakup point. ...more
1 | Renalytix to Participate in the BTIG MedTech, Digital Health, Life Science Diagnostic Tools Conference | 02/09/2024 |
2 | Renalytix stock surges after Medicare decision | 02/12/2024 |
3 | Why Is Kidney-Disease Diagnostic Focused Renalytix Stock Trading Higher Today | 02/29/2024 |
4 | Why Is AI-Powered Diagnostic Firm Renalytix Stock Soaring On Monday | 03/04/2024 |
5 | RNLX Stock Quote Price and Forecast - CNN | 03/07/2024 |
6 | KidneyIntelX included in Final KDIGO 2024 Clinical Guideline for Chronic Kidney Disease | 03/14/2024 |
7 | Discretionary transaction by Mills Christopher of tradable shares of Renalytix subject to Rule 16b-3 | 03/25/2024 |
8 | Renalytix Announces Financing with Expected Size of up to 4 Million | 04/08/2024 |
9 | Renalytix files to sell 19.99M ordinary shares for holders | 04/17/2024 |
10 | Renalytix AI Announces Fundraising, Executive Changes, and Shareholder Approval - TipRanks.com - TipRanks | 04/23/2024 |
Begin Period Cash Flow | 41.3 M |
Renalytix |
Renalytix Relative Risk vs. Return Landscape
If you would invest 32.00 in Renalytix AI on January 26, 2024 and sell it today you would earn a total of 32.00 from holding Renalytix AI or generate 100.0% return on investment over 90 days. Renalytix AI is currently generating 4.0464% in daily expected returns and assumes 33.6236% risk (volatility on return distribution) over the 90 days horizon. In different words, most equities are less risky than Renalytix, and most traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
Risk |
Renalytix Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Renalytix's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Renalytix AI, and traders can use it to determine the average amount a Renalytix's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.1203
Best Portfolio | Best Equity | RNLX | ||
Good Returns | ||||
Average Returns | ||||
Small Returns | ||||
Cash | Small Risk | Average Risk | High Risk | Huge Risk |
Negative Returns |
Estimated Market Risk
33.62 actual daily | 96 96% of assets are less volatile |
Expected Return
4.05 actual daily | 80 80% of assets have lower returns |
Risk-Adjusted Return
0.12 actual daily | 9 91% of assets perform better |
Based on monthly moving average Renalytix is performing at about 9% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Renalytix by adding it to a well-diversified portfolio.
Renalytix Fundamentals Growth
Renalytix Stock prices reflect investors' perceptions of the future prospects and financial health of Renalytix, and Renalytix fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Renalytix Stock performance.
Return On Equity | -6.51 | ||||
Return On Asset | -0.88 | ||||
Operating Margin | (11.76) % | ||||
Current Valuation | 72.77 M | ||||
Shares Outstanding | 63.11 M | ||||
Price To Book | 20.68 X | ||||
Price To Sales | 22.89 X | ||||
Revenue | 3.4 M | ||||
Gross Profit | 720 K | ||||
EBITDA | (35.5 M) | ||||
Net Income | (46.22 M) | ||||
Cash And Equivalents | 32.36 M | ||||
Cash Per Share | 0.89 X | ||||
Total Debt | 12.15 M | ||||
Debt To Equity | 0.01 % | ||||
Current Ratio | 2.48 X | ||||
Book Value Per Share | (0.08) X | ||||
Cash Flow From Operations | (32.67 M) | ||||
Earnings Per Share | (0.90) X | ||||
Market Capitalization | 45.3 M | ||||
Total Asset | 42.12 M | ||||
Retained Earnings | (99.18 M) | ||||
Working Capital | 12.2 M | ||||
About Renalytix Performance
To evaluate Renalytix AI Stock as a possible investment, you need to clearly understand its upside potential, downside risk, and overall future performance outlook. You may be satisfied when Renalytix generates a 15% return over the last few months, but what if the market is generating 25% over the same period? In this case, it makes sense to compare Renalytix Stock's performance with different market indexes, such as the Dow or NASDAQ Composite. These indexes can act as benchmarks that will help you to understand Renalytix AI market performance in a much more refined way. The Macroaxis performance score is an integer between 0 and 100 that represents Renalytix's market performance from a risk-adjusted return perspective. Generally speaking, the higher the score, the better is overall performance as compared to other investors. The score is normalized against the average investing universe (the best we can interpret from the data available). Within this methodology, scores of individual equity instruments will always be inferior to the scores of portfolios of equities as portfolios typically diversify a lot of unsystematic risks away. The formula to derive the Macroaxis score bases on multiple unequally-weighted factors. For more information, refer to our portfolio performance evaluation section.
Please also refer to our technical analysis and fundamental analysis pages.Last Reported | Projected for Next Year | ||
Days Of Inventory On Hand | 111.54 | 105.96 | |
Return On Tangible Assets | (1.80) | (1.71) | |
Return On Capital Employed | (1.87) | (1.78) | |
Return On Assets | (1.26) | (1.20) | |
Return On Equity | (2.88) | (2.74) |
Things to note about Renalytix AI performance evaluation
Checking the ongoing alerts about Renalytix for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Renalytix AI help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.Renalytix AI is way too risky over 90 days horizon | |
Renalytix AI has some characteristics of a very speculative penny stock | |
Renalytix AI appears to be risky and price may revert if volatility continues | |
Renalytix AI has high likelihood to experience some financial distress in the next 2 years | |
The company reported the previous year's revenue of 3.4 M. Net Loss for the year was (46.22 M) with profit before overhead, payroll, taxes, and interest of 720 K. | |
Renalytix AI currently holds about 32.36 M in cash with (32.67 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.89, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
Renalytix AI has a poor financial position based on the latest SEC disclosures | |
Latest headline from news.google.com: Renalytix AI Announces Fundraising, Executive Changes, and Shareholder Approval - TipRanks.com - TipRanks |
- Analyzing Renalytix's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Renalytix's stock is overvalued or undervalued compared to its peers.
- Examining Renalytix's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Renalytix's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Renalytix's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Renalytix's stock. These opinions can provide insight into Renalytix's potential for growth and whether the stock is currently undervalued or overvalued.
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Renalytix AI. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of economic analysis. You can also try the Sync Your Broker module to sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors..
Complementary Tools for Renalytix Stock analysis
When running Renalytix's price analysis, check to measure Renalytix's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Renalytix is operating at the current time. Most of Renalytix's value examination focuses on studying past and present price action to predict the probability of Renalytix's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Renalytix's price. Additionally, you may evaluate how the addition of Renalytix to your portfolios can decrease your overall portfolio volatility.
Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
Global Correlations Find global opportunities by holding instruments from different markets | |
USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing |
Is Renalytix's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Renalytix. If investors know Renalytix will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Renalytix listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.90) | Revenue Per Share 0.052 | Quarterly Revenue Growth (0.41) | Return On Assets (0.88) | Return On Equity (6.51) |
The market value of Renalytix AI is measured differently than its book value, which is the value of Renalytix that is recorded on the company's balance sheet. Investors also form their own opinion of Renalytix's value that differs from its market value or its book value, called intrinsic value, which is Renalytix's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Renalytix's market value can be influenced by many factors that don't directly affect Renalytix's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Renalytix's value and its price as these two are different measures arrived at by different means. Investors typically determine if Renalytix is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Renalytix's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.